These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37625901)

  • 1. Effect of Systemic Administration of CD4
    Christensen PK; Hansen AK; Skov S; Larsen J; Høyer-Hansen MH; Koch J
    Comp Med; 2023 Aug; 73(4):285-293. PubMed ID: 37625901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.
    Nickoloff BJ; Wrone-Smith T
    Am J Pathol; 1999 Jul; 155(1):145-58. PubMed ID: 10393847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustaining the T-cell activity in xenografted psoriasis skin.
    Christensen PKF; Hansen AK; Skov S; Engkilde K; Larsen J; Høyer-Hansen MH; Koch J
    PLoS One; 2023; 18(1):e0278390. PubMed ID: 36649237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice.
    Gilhar A; David M; Ullmann Y; Berkutski T; Kalish RS
    J Invest Dermatol; 1997 Sep; 109(3):283-8. PubMed ID: 9284091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
    Szabo SK; Hammerberg C; Yoshida Y; Bata-Csorgo Z; Cooper KD
    J Invest Dermatol; 1998 Dec; 111(6):1072-8. PubMed ID: 9856819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
    Chen Y; Yan Y; Liu H; Qiu F; Liang CL; Zhang Q; Huang RY; Han L; Lu C; Dai Z
    Theranostics; 2020; 10(23):10466-10482. PubMed ID: 32929360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Xenogeneic Graft-Versus-Host Disease Model for Investigating the Pathological Role of Human CD4
    Ito R; Katano I; Kawai K; Yagoto M; Takahashi T; Ka Y; Ogura T; Takahashi R; Ito M
    Am J Transplant; 2017 May; 17(5):1216-1228. PubMed ID: 27862942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
    Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
    J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines?
    Baker BS; Brent L; Valdimarsson H; Powles AV; al-Imara L; Walker M; Fry L
    Br J Dermatol; 1992 Feb; 126(2):105-10. PubMed ID: 1536776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4
    Chen Y; Zhang Q; Liu H; Lu C; Liang CL; Qiu F; Han L; Dai Z
    Front Immunol; 2018; 9():2092. PubMed ID: 30258447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate.
    Zeigler M; Chi Y; Tumas DB; Bodary S; Tang H; Varani J
    Lab Invest; 2001 Sep; 81(9):1253-61. PubMed ID: 11555673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal injection of immunocytes induces psoriasis.
    Wrone-Smith T; Nickoloff BJ
    J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
    Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
    Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.
    Kundu-Raychaudhuri S; Chen YJ; Wulff H; Raychaudhuri SP
    J Autoimmun; 2014 Dec; 55():63-72. PubMed ID: 25175978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of CD4+ and CD8+ T cells in discordant skin xenograft rejection.
    Uchida T; Tomita Y; Anzai K; Zhang QW; Yoshikawa M; Kishihara K; Nomoto K; Yasui H
    Transplantation; 1999 Dec; 68(11):1721-7. PubMed ID: 10609949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.
    Günther C; Carballido-Perrig N; Kaesler S; Carballido JM; Biedermann T
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):626-34. PubMed ID: 22113484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
    Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
    PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model.
    Al-Harbi NO; Ahmad SF; Almutairi M; Alanazi AZ; Ibrahim KE; Alqarni SA; Alqahtani F; Alhazzani K; Alharbi M; Alasmari F; Nadeem A
    Cell Immunol; 2022 Jun; 376():104531. PubMed ID: 35576719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.